Emerging investigations areing on specially designed small protein chains, a unique class of agents demonstrating considerable potential for affecting different condition processes. Distinct from existing drug approaches, Nexaph peptides offer superior specificity and lesser side effects, making them a truly encouraging option for next-generation d